The demand for MRI-Safe CRT Devices Market is skyrocketing, reflecting a growing need for advanced cardiac care solutions. According to industry experts, the market is poised for a stellar rise, reaching a colossal US$1.5 billion by 2032. This phenomenal growth translates to a robust Compound Annual Growth Rate (CAGR) of 9.6%, significantly outpacing the 2022 valuation of US$550.5 million.
Global MRI-Safe CRT Devices Industry Overview
MRI-safe cardiac resynchronization therapy is the method used to improve the heart’s efficiency by increasing the oxygen and blood flow rate in the body. Patients suffering from heart failure syndromes such as shortness of breath, fatigue, swelling of the feet and legs, diminished appetite, exercise intolerance, and depression or have developed arrhythmia benefit from MRI-safe cardiac resynchronization therapy devices.
Request a Sample of this Report Now Use Work Email to Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5265
Clinical studies suggest that the use of MRI-safe cardiac resynchronization therapy devices has reduced the number of hospitalization cases and the morbidity rate and also leads to the improvement in the quality of patient’s life. Moreover, MRI-safe cardiac resynchronization therapy device treats patients with moderate as well as severe symptoms of heart failure and the effectiveness of the therapy is equal in both men and women.
The MRI-safe cardiac resynchronization therapy devices are implanted in the body. The device is a pocket-sized pacemaker and is implanted just below the collarbone. The leads from the device, monitor the heart rate to detect the heart rate abnormalities and transmit small pulses to resynchronize the heart’s ventricles. The therapy device improves the heart rhythm and the symptoms associated with arrhythmia.
MRI-Safe CRT Devices Market: Drivers & Restraints
The global MRI-safe cardiac resynchronization therapy market is anticipated to experience an upsurge in the forecast period with the increasing prevalence of heart-associated disorders including congestive heart failure and cardiomyopathy. The effectiveness of the MRI-safe cardiac resynchronization therapy devices and their compatibility with medical resonance imaging has enhanced the overall market for MRI-safe cardiac resynchronization therapy devices market.
The awareness programs conducted by various healthcare sectors as well as government organizations, for spreading the information related to heart and diseases related to it is driving the MRI-safe cardiac resynchronization therapy device market globally. However, the lack of trained and skilled professionals and the high cost of the cardiac resynchronization therapy device are restraining the growth of the MRI-safe cardiac synchronization therapy device market. In addition, the lack of interoperability of data formats is also the reason for restraining the growth of the MRI-safe cardiac resynchronization therapy device market.
Global MRI-Safe CRT Devices Industry: Overview
MRI-safe cardiac resynchronization therapy device defibrillators (CRT-D) incorporate the function of an implantable cardioverter-defibrillator, that quickly resynchronizes a life-threatening, abnormally fast heart rhythm. MRI-safe cardiac resynchronization therapy Pacemakers and Defibrillators have increasingly important therapeutic applications for patients with severe and moderate heart failure. The acute care treatment is projected to improve the global market for MRI-safe cardiac resynchronization therapy devices.
MRI-Safe CRT Devices Industry: Regional Overview
Based on geography, the global MRI safe cardiac resynchronization therapy device market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is slated to dominate the global MRI safe cardiac resynchronization therapy device market throughout the forecast period owing to the presence of skilled and trained professionals.
Europe is the next to hold the largest share in the global MRI-safe cardiac resynchronization therapy device market. The increasing healthcare expenditure in Europe’s Medical industry has forced various healthcare organizations to adopt new innovative technological advancements. Asia Pacific is projected to experience rapid growth in the global MRI safe cardiac resynchronization therapy device market with increasing prevalence cases of heart disorders and the rising awareness to overcome them.
Request Your Customized Report Now
https://www.futuremarketinsights.com/customization-available/rep-gb-5265
MRI-Safe CRT Devices Market: Key Players
The major players in the global MRI-safe cardiac resynchronization therapy device market are St. Jude Medical, LLC, Medtronic, Scranton Gillette Communications, and Boston Scientific Corporation.
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends Issues and Challenges
- Competition and companies involved
- Technology
- Value Chain
Key Segments Profiled in the MRI-Safe CRT Devices Market Survey
By Product Type:
- Defibrillator
- Pacemaker
By Age Group:
- Pediatric
- Geriatric
By Indication:
- Cardiomyopathy
- Bradycardia
- Electrocardiography
- Congestive Heart Failure
Click Here To Purchase Your Detailed Report
https://www.futuremarketinsights.com/checkout/5265
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
